Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy.

Shang-Yu ChouShao-Lun YenChao-Cheng HuangEng-Yen Huang

Published in: BMC cancer (2018)

The expression level of galectin-1 affects survival in patients with GBM treated with adjuvant RT. Future studies are required to analyze the effect of other factors, such as O(6)-methylguanine-DNA methyltransferase (MGMT)-promoter methylation status, in patients with weak and strong galectin-1 expression.

Keyphrases

prognostic factors
poor prognosis
early stage
dna methylation
gene expression
binding protein
single molecule
circulating tumor
long non coding rna
current status
radiation induced
cell free
newly diagnosed
nucleic acid